Abstract:BACKGROUND:Recombinant adeno-associated virus (rAAV) is increasingly applied in neuroscience research or gene therapy. However, there is no simple and efficient tool for specific transfection of rAAV into cerebrovascular tissues. It has been reported that fluorescent tracers or beta-amyloid protein can enter the brain through perivascular spaces, named as "glymphatic system". The purpose of this study was to explore whether rAAV could transduce the cerebral vasculature through the glymphatic pathway.NEW METHOD:An AAV1-GFP vector suspension (15 μL) was injected into the intracisternal space of anesthetized mice (n = 2) and 5 μl was injected into the bulbus medullae (n = 2). As controls, 15 μl of artificial cerebrospinal fluid (aCSF) was injected into the cisterna magna. The endothelial specific transduction was verified by Glut1 or PDGFRβ immunofluorescent staining. Immunofluorescence images for all groups were captured with a laser microscope.RESULTS:It was observed that infection with rAAV1 vectors encoding green fluorescence protein resulted in a successful cerebrovascular transduction when injected into cisterna magna, compared to aCSF or intra-parenchymal injection at 30 days post-transduction in adult mice. In addition, GFP was co-localized with Glut1 based on immuno-fluorescence. These results indicate that glymphatic system delivery enhances the transduction efficiency of AAV1 to brain endothelial cells.COMPARISON WITH EXISTING METHODS:The AAV1 vector can simply and efficiently transduce the cerebral endothelial cells through the glymphatic pathway.CONCLUSION:The findings of this study reveal that rAAV1-based vectors have high application potential for endothelial-targeted neurologic disease research or gene-based therapies.

Identification of cis-regulatory modules for adeno-associated virus-based cell-type-specific targeting in the retina and brain

Identification of &Lt;i>cis</i>-Regulatory Modules for Aav-Based Cell Type-Specific Targeting in the Retina and Brain

An enhancer-AAV toolbox to target and manipulate distinct interneuron subtypes

Viral vectors with cluster of differentiation gene promoters to target specific cell types in the brain

Identification of Broadly Applicable Adeno-Associated Virus Vectors by Systematic Comparison of Commonly Used Capsid Variants In Vitro

The Glymphatic System Delivery Enhances the Transduction Efficiency of AAV1 to Brain Endothelial Cells in Adult Mice.

AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation

Enhancer AAVs for targeting spinal motor neurons and descending motor pathways in rodents and macaque

Hardwiring tissue-specific AAV transduction in mice through engineered receptor expression

Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans

Functional enhancer elements drive subclass-selective expression from mouse to primate neocortex

Enhancer-AAVs allow genetic access to oligodendrocytes and diverse populations of astrocytes across species

Engineered AAV13 variants with enhanced transduction and confined spread

Directed Evolution of Adeno-Associated Virus for Efficient Gene Delivery to Microglia

Common AAV gene therapy vectors show indiscriminate transduction of living human brain cell types

CRISPR screening by AAV episome-sequencing (CrAAVe-seq) is a highly scalable cell type-specific in vivo screening platform

Simple and highly specific targeting of resident microglia with adeno-associated virus

Microglia-specific transduction via AAV11 armed with IBA1 promoter and miRNA-9 targeting sequences

Viral Manipulation of Functionally Distinct Neurons from Mice to Humans

CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector

Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluations